Clinical trials in Saint Quentin

Groundbreaking research focusing on Multiple Myeloma treatments, including innovative combination therapies and maintenance approaches. Studies evaluate novel treatments like elranatamab and daratumumab for both newly diagnosed and relapsed cases.

• Treatment optimization for various disease stages
• Novel drug combinations
• Maintenance therapy strategies

Additional trials explore treatments for Polycythemia Vera and other hematologic conditions.

Extensive studies on Non-Small Cell Lung Cancer investigating immunotherapy combinations and targeted treatments. Research includes trials for both early-stage and metastatic disease, with particular focus on specific genetic mutations.

• Immunotherapy combinations
• Targeted therapies for specific mutations
• Novel treatment approaches for advanced disease

Includes studies on ALK-positive and BRAF-mutant variants.

Innovative research in colorectal cancer treatment, particularly focusing on minimal residual disease detection and personalized treatment approaches using circulating tumor DNA analysis.

• Biomarker-driven treatment decisions
• Post-surgical therapy optimization
• Advanced stage disease management

Studies aim to improve patient outcomes through precise treatment selection.